From seed to win.
Content
Content
Team
Team
Companies
Companies
Guild
Guild
Focus Areas
Focus Areas
Bio
Gaming
Generative AI
Proptech
Space
Fintech
Marketplaces
Crypto
Israel
LatAm
Products
Products
Signal
Brieflink
NFX Masterclass
Join 222K+ Subscribers.
Subscribe
Omri Amirav-Drory, Ph.D.
18
Focus Areas
All Focus Areas
Bio
· 15
Gaming
· 6
Generative AI
· 13
PropTech
· 3
LatAm
· 4
Israel
· 6
Space
· 2
Fintech
· 5
Marketplaces
· 24
Crypto
· 20
By Author
Morgan Beller
Omri Amirav-Drory, Ph.D.
Pete Flint
Gigi Levy-Weiss
James Currier
Topics
Network Effects
· 34
Fundraising
· 24
Growth
· 109
Leadership
· 52
Investment Memos
· 56
Psychology
· 43
Announcements
· 20
By Type
All NFX Content
· 352
Videos
· 35
Podcasts
· 92
Essays
· 148
Omri Amirav-Drory, Ph.D. · 18
Featured
The Next Industrial Revolution: Computational Biology & Bioplatforms
Featured
NFX Bio: Investing in Scientist-Founders from the Very Beginning with Omri Amirav-Drory
Featured
A Mammoth Becomes A Unicorn: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D
Featured
Why C2i is the World’s First Platform for Cancer Intelligence
Maximizing TechBio Deal Potential: Platform vs. Asset Deals
Deal or Die: Your 3-Part Guide to Business Development in TechBio
Tech Founders, Don’t Be Afraid of Bio
What Doesn’t Kill You, Mutates And Tries Again
From Sick Care to Health Care: Why We Need Longevity Startups
How to Prove Your TechBio Platform at Seed Stage
Why NFX Invested in Centivax: The TechBio Platform Developing Universal Vaccines
Academia or Startup? A Decision Matrix for Future Scientist-Founders
The Golden Ratio: Navigating East Coast v. West Coast in TechBio Investing
From Biotech to TechBio
Why NFX Invested in Pangea Biomed, the Startup Matching Cancer Patients with the Right Therapies
Why NFX Invested in Pepper Bio: The ‘Waze for Drug Discovery’ Will Treat the Untreatable
Launching NFX Bio and The Rise of the Scientist Founder
Difference Between BioTech & TechBio
Featured
The Next Industrial Revolution: Computational Biology & Bioplatforms
Featured
NFX Bio: Investing in Scientist-Founders from the Very Beginning with Omri Amirav-Drory
Featured
A Mammoth Becomes A Unicorn: Inside a Scientist-Founder’s Journey from Pre-Seed to Series D
Featured
Why C2i is the World’s First Platform for Cancer Intelligence
Maximizing TechBio Deal Potential: Platform vs. Asset Deals
Deal or Die: Your 3-Part Guide to Business Development in TechBio
Tech Founders, Don’t Be Afraid of Bio
What Doesn’t Kill You, Mutates And Tries Again
From Sick Care to Health Care: Why We Need Longevity Startups
How to Prove Your TechBio Platform at Seed Stage
Why NFX Invested in Centivax: The TechBio Platform Developing Universal Vaccines
Academia or Startup? A Decision Matrix for Future Scientist-Founders
The Golden Ratio: Navigating East Coast v. West Coast in TechBio Investing
From Biotech to TechBio
Why NFX Invested in Pangea Biomed, the Startup Matching Cancer Patients with the Right Therapies
Why NFX Invested in Pepper Bio: The ‘Waze for Drug Discovery’ Will Treat the Untreatable
Launching NFX Bio and The Rise of the Scientist Founder
Difference Between BioTech & TechBio
Join the 222K+ Founders subscribed to our newsletter.
Submit